Skip to main content
Official Website of Stem Cell Mexico – Since 2002
Stem Cell Therapy Mexico

How is stem cell treatment for hearing loss done?

At Stem Cell Mexico, stem cell treatment for hearing loss is a structured, minimally invasive process.

Free Consultation
Ears location on a neutral human figure

It begins with a review of your audiogram and ear, nose and throat (ENT) reports, continues with a consultation with the doctor, a written plan and an in-person evaluation, and centers on the application of allogeneic mesenchymal stem cells (MSCs) from Wharton's jelly of the umbilical cord, usually by intravenous (IV) infusion, followed by observation and follow-up with repeat hearing tests. No autologous cells or other cell sources are used. Direct injection of cells into the inner ear is not part of routine care; it is explored only in research settings because of its additional risks. Because results vary, the process is designed to confirm first that proven treatments have been considered and that expectations are realistic. The number of applications is not fixed in advance; it is defined individually and only when there is a medical reason.

This guide walks through each step, explains why the route matters for the ear and describes how results should be measured.

Why the process starts with a hearing diagnosis

Hearing loss is not a single condition. Earwax, fluid in the middle ear, infections, a perforated eardrum, otosclerosis, aging, noise exposure, genetics, medications that damage the ear, autoimmune disease and tumors of the hearing nerve can all reduce hearing. Some of these causes are treatable with standard medicine or surgery, and a few, such as tumors, need urgent attention. For this reason, the first step is always to understand the type and cause of your hearing loss.

If your hearing dropped suddenly, seek medical care immediately. Sudden sensorineural hearing loss is a medical emergency, often treated with corticosteroids, and outcomes are better when treatment starts within days. Do not delay emergency care to pursue a regenerative treatment.

A typical itinerary

A common itinerary looks like this:

  • Day 1: pickup in the San Diego area, border crossing with a driver, laboratory tests and an in-person consultation with the doctor.
  • Day 2: cell application by IV infusion, followed by observation, usually overnight under nursing supervision.
  • Day 3: check-up with the doctor, discharge instructions and return to San Diego.

The exact itinerary is confirmed in your written plan.

Step 1: Records review

You send:

  • A recent audiogram (ideally within the past six months), including pure-tone thresholds and speech recognition scores for each ear.
  • ENT evaluation notes and, if performed, tympanometry, otoacoustic emissions or auditory brainstem response tests.
  • Imaging reports (MRI or CT) if they were requested by your specialist.
  • Information about hearing aids or cochlear implants you use or have tried.
  • A complete list of medications and medical conditions.

The medical team uses this information to confirm the type of hearing loss and to identify causes that need standard treatment first.

Step 2: Consultation with the doctor

A complimentary phone or video consultation allows the doctor to understand your history and goals, explain what regenerative treatment can and cannot do for hearing loss, and discuss whether you may be a candidate. The doctor will explain that:

  • Stem cell therapy is not designed to restore normal hearing.
  • Hearing aids and cochlear implants remain the treatments with proven benefit.
  • Results, if any, vary between individuals and may be absent.

Goals are defined specifically, such as changes in hearing thresholds, speech understanding or tinnitus perception, so they can be measured later.

Step 3: Written plan and preparation

If treatment is considered appropriate, you receive a written plan describing the cell dose, route, itinerary, inclusions and costs. Typical preparation instructions include:

  • Pausing anti-inflammatory painkillers, alcohol, tobacco and cannabis for about seven days before treatment, and supplements such as omega 3, turmeric and ginger for about five days before, as the doctor indicates.
  • Continuing essential prescribed medications unless the doctor tells you otherwise.
  • Arriving fasting on the morning of the procedure.
  • Bringing your hearing aids and any communication aids you use, so the team can communicate clearly with you.

Step 4: Arrival and evaluation

On arrival, you have blood tests, including a complete blood count, metabolic panel, urinalysis and tumor markers, and an in-person evaluation with the doctor. Your ears are examined and vital signs recorded. If anything suggests treatment would not be safe that day, such as an active ear or systemic infection, it is postponed.

Step 5: The cell application

The cells

The cells are allogeneic MSCs from Wharton's jelly of donated umbilical cords, obtained after healthy, full-term births with informed consent and donor screening. They are produced in a COFEPRIS-licensed laboratory under Good Manufacturing Practice standards, with quality and safety testing before release.

The route

The usual route is intravenous infusion:

  1. A small IV catheter is placed in your arm.
  2. Baseline vital signs are recorded.
  3. The cells are infused slowly, usually over 30 to 60 minutes.
  4. Blood pressure, heart rate, oxygen and temperature are monitored during and after the infusion.

The inner ear is protected by a blood-labyrinth barrier, similar to the barrier that protects the brain, and after IV infusion many cells are temporarily filtered by the lungs. This means few cells, if any, are expected to reach the cochlea. Any potential effect is believed to come from circulating anti-inflammatory and protective signals.

Other routes in research

Researchers have explored delivering cells or biological agents through the eardrum into the middle ear or directly into the cochlea. These approaches can bring therapies closer to the target, but they carry risks such as further hearing loss, dizziness, infection and eardrum perforation, and they are performed only within specialized research protocols.

Step 6: Observation

After the infusion, you remain under observation, usually overnight. Nurses monitor vital signs and watch for temporary fever, headache or fatigue, which are the most common reactions reported in safety studies. Paracetamol and cooling measures are used if fever appears. No medical treatment is free of risk, and the team explains what to watch for after you leave.

Step 7: Discharge and recovery

Before discharge, the doctor reviews how you feel and gives written instructions:

  • Rest on the day of treatment and the following day.
  • Expect possible mild fever, headache or fatigue for a day or two.
  • Continue using your hearing aids as usual.
  • Avoid loud noise exposure, alcohol and anti-inflammatory painkillers as instructed.
  • Contact the clinic or seek care if you notice fever that persists, ear pain, discharge, sudden worsening of hearing or severe dizziness.

Step 8: Follow-up and measurement

The best way to know whether anything changed is objective testing. We recommend:

  • A repeat audiogram with speech recognition testing at about three and six months, ideally by the same audiologist and under the same conditions as your baseline.
  • Recording tinnitus severity with a validated questionnaire if it is one of your concerns.
  • Sharing results with your ENT and audiologist so your hearing plan, including hearing aid settings, can be adjusted.

Small day-to-day fluctuations in perceived hearing are common and can be influenced by fatigue, background noise and earwax, so impressions alone are not reliable.

Recovery is gradual, and each person responds differently. Some patients begin noticing changes within the first weeks, while others notice them over the following months, which is why our team stays in contact after treatment to follow your progress and decide whether a second application could help.

How the treatment fits with standard care

According to the World Health Organization's World report on hearing, hearing aids, cochlear implants, rehabilitation and prevention are the foundations of hearing care. Stem cell therapy, if used, is an addition to these measures, not a replacement. If your hearing loss is severe or profound, a cochlear implant evaluation should be part of your plan.

We also encourage you to keep your ENT and audiologist informed before and after treatment. Their baseline and follow-up testing provides an independent record of your hearing and helps you and your care team make informed decisions about next steps.

Who may be a candidate

  • Sensorineural hearing loss with a documented cause and recent audiological evaluation.
  • Conductive and treatable causes already addressed through standard care.
  • No active ear infection, no untreated tumor and no cancer within the past five years.
  • Realistic expectations, including the possibility of no change in hearing.

Questions to ask during your evaluation

  • What type and cause of hearing loss do I have?
  • Have I explored hearing aids or a cochlear implant fully?
  • Which route and dose are proposed, and why?
  • How will my hearing be measured before and after treatment?
  • What are the possible risks in my situation?

Bottom line

Stem cell treatment for hearing loss at Stem Cell Mexico follows a step-by-step process: records review, consultation, preparation, evaluation, IV application of Wharton's jelly MSCs with monitoring, observation and follow-up with repeat audiometry. The treatment is a supportive option that complements, not replaces, proven hearing care. A medical evaluation can help determine whether this type of regenerative treatment is appropriate for your hearing condition, goals and medical history.

References

  1. World Health Organization (WHO): World report on hearing, 2021 (opens in a new tab)
  2. Fang Q et al. Stem cells as potential therapeutics for hearing loss. Frontiers in Neuroscience, 2023 (opens in a new tab)
  3. Dufner-Almeida LG et al. Stem-cell therapy for hearing loss: are we there yet? Brazilian Journal of Otorhinolaryngology, 2019 (opens in a new tab)
  4. Caplan H, Olson SD, Cox CS Jr et al. Mesenchymal stromal cell therapeutic delivery: translational challenges to clinical application. Frontiers in Immunology, 2019 (opens in a new tab)

Request your medical evaluation

A clearer path starts here.

Tell us a little about yourself. We’ll help you understand the next step.

Vania, patient coordinator at Stem Cell Mexico

Vania, our patient coordinator

Your questions. Your travel plans.
A real person to help.

Talk to Vania on WhatsApp (opens in a new tab)

What happens next?

  1. Your advisor contacts you.
  2. We explain the medical review.
  3. You explore your options.

Call +1 800 646 0290

Let’s begin with you.

Your inquiry starts a conversation. Treatment requires medical evaluation.

Vania · Patient Advisor

Start my free evaluation
Free Consultation